D-0268-2022 Class III Terminated
FDA drug recall D-0268-2022 was initiated by Dr. Reddy's Laboratories, Inc. on November 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated June 23, 2023). Affected quantity: 14976 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- December 15, 2021
- Initiation Date
- November 12, 2021
- Termination Date
- June 23, 2023
- Voluntary/Mandated
- N/A
- Product Quantity
- 14976 cartons
Product Description
Allergy & Congestion Relief Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets, 20 extended-release tablets, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, Made in India, NDC 69842-249-20
Reason for Recall
Failed dissolution specifications
Distribution Pattern
USA Nationwide.
Code Information
Lot #: AC2103329I, Exp 1/2023